|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-9-30
|
|
pubmed:abstractText |
In this study, we retrospectively assessed the performance of 18-F-fluorodeoxyglucose positron emission tomography (FDG-PET) compared with computed tomography (CT) and esophagography for assessing the response of advanced esophageal squamous cell carcinoma (SCC) to neoadjuvant chemoradiotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0002-9610
|
|
pubmed:author |
pubmed-author:EndoKeigoK,
pubmed-author:FukuchiMinoruM,
pubmed-author:KatoHiroyukiH,
pubmed-author:KuwanoHiroyukiH,
pubmed-author:MandaRyokuheiR,
pubmed-author:MasudaNorihiroN,
pubmed-author:MiyazakiTatsuyaT,
pubmed-author:NakajimaMasanobuM,
pubmed-author:OriuchiNoboruN,
pubmed-author:TsukadaKatsuhikoK,
pubmed-author:YoshikawaMinakoM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
184
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
279-83
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12354600-Adult,
pubmed-meshheading:12354600-Aged,
pubmed-meshheading:12354600-Carcinoma, Squamous Cell,
pubmed-meshheading:12354600-Chemotherapy, Adjuvant,
pubmed-meshheading:12354600-Esophageal Neoplasms,
pubmed-meshheading:12354600-Female,
pubmed-meshheading:12354600-Fluorodeoxyglucose F18,
pubmed-meshheading:12354600-Humans,
pubmed-meshheading:12354600-Male,
pubmed-meshheading:12354600-Middle Aged,
pubmed-meshheading:12354600-Neoadjuvant Therapy,
pubmed-meshheading:12354600-Predictive Value of Tests,
pubmed-meshheading:12354600-Radiopharmaceuticals,
pubmed-meshheading:12354600-Radiotherapy, Adjuvant,
pubmed-meshheading:12354600-Retrospective Studies,
pubmed-meshheading:12354600-Tomography, Emission-Computed,
pubmed-meshheading:12354600-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer.
|
|
pubmed:affiliation |
Department of Surgery I, Gunma University Faculty of Medicine, 3-39-22, Showa-machi, Maebashi 371-8511, Japan. hiroyuki@po.wind.ne.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
